General Information of Drug (ID: DMJO3DB)

Drug Name
Mycobacterial cell wall-DNA complex
Synonyms MCC; Prostacidin; Regressin; Urocidin; EN-3348; Mycobacterial cell wall-DNA complex, Bioniche
Indication
Disease Entry ICD 11 Status REF
Solid tumour/cancer 2A00-2F9Z Phase 3 [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
Chemical Identifiers
Formula
C8H7Cl2NO2
Canonical SMILES
COC(=O)NC1=CC(=C(C=C1)Cl)Cl
InChI
InChI=1S/C8H7Cl2NO2/c1-13-8(12)11-5-2-3-6(9)7(10)4-5/h2-4H,1H3,(H,11,12)
InChIKey
WOZQBERUBLYCEG-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
15969
ChEBI ID
CHEMBL82188
CAS Number
1918-18-9
DrugBank ID
DB05282
TTD ID
D0NL5M
Drug-Molecule Activity Atlas (DMA)NEW Click to Jump to the Detailed DMA Information of This Drug
Drug ADMET Endpoint Profile (DAE)NEW Click to Jump to the Detailed DAE Information of This Drug

References

1 ClinicalTrials.gov (NCT01200992) Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer. U.S. National Institutes of Health.